Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-27

Clinical Trial Update: Shivering Treatment After Cesarean Delivery: Meperidine vs. Dexmedetomidine [Phase 3]

View source ↗

Summary

Phase 3 trial comparing meperidine to dexmedetomidine for shivering after cesarean delivery; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Meperidine (Meperidine)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Cesarean Section Complications | Phase 3 | Status: COMPLETED